Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-29

Clinical Trial Update: INtravitreal and Aqueous Dexamethasone Levels After DEXtenza [Phase 4]

View source ↗

Summary

A Phase 4 trial update on dexamethasone levels after DEXtenza (intravitreal and aqueous) in ocular disease requiring surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)

Snippet

Sponsor: Nathan Steinle | Conditions: Ocular Disease Requiring Surgery | Phase 4 | Status: UNKNOWN